XTLB (XTLB) Stock Price & Analysis
XTLB (XTLB) rose 1.20% to USD 2.53 as of September 8, 2026 at 12:00 UTC, according to Nexqual real-time market data.
XTLB last closed at USD 2.53; the session ranged USD 2.43–2.53 on volume of 1,817 shares. Market capitalization is —, with a 52-week range of USD 2.01–10.28 (NCM). Source: Nexqual, September 8, 2026 at 12:00 UTC.
Key Statistics (as of September 8, 2026 at 12:00 UTC)
| Price | USD 2.53 |
|---|---|
| Change | ▲ 1.20% (up) |
| Previous Close | USD 2.53 |
| Open | USD 2.53 |
| Day Range | USD 2.43 – 2.53 |
| 52-Week Range | USD 2.01 – 10.28 |
| Volume | 1,817 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (XTLB)
Nexqual's technical model rates XTLB "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 12:00 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 44.46 (neutral) |
| vs SMA50 | Below (USD 2.78) |
| MACD | -0.09 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| XBIO | Xenetic Biosciences, Inc. | USD 4.67 | ▲ 9.88% |
| BNTC | Benitec Biopharma Inc. | USD 12.68 | ▼ 1.55% |
| KZIA | Kazia Therapeutics Limited | USD 12.31 | ▼ 2.38% |
| ZCMD | Zhongchao Inc. | USD 0.85 | ▼ 7.42% |
| TENX | Tenax Therapeutics, Inc. | USD 1.94 | ▲ 4.86% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 12:00 UTC. This page is informational and not investment advice.